Abstract:Multiple myeloma (MM) is an indolent B-cell disease characterized by clonal proliferation of malignant plasma cells. Multiple myeloma remains incurable despite new targeted drugs and development of drug resistance or intolerable toxicity emerges as a major problem. Therefore, design, identification, and validation of novel chemicals with therapeutic potential are clearly needed for MM treatment. Here, we explore polyphyllin I (PPI), a major active constituent extracted from Paris polyphyllin, its inhibitory effects and its mechanisms in MM cells in vitro. We found that PPI inhibited the proliferation of myeloma cells. The combination of PPI with dexamethasone, doxorubicin, arsenic trioxide, or bortezomib enhanced the inhibition of cell growth. As analyzed by flow cytometry, MM cells were arrested at G2/M phase and apoptotic cells increased in a time-dependent manner. Morphological changes of cells undergoing apoptosis were observed under light microscope. To explore the mechanism of apoptosis induced by PPI, we next examined whether the Wingless-Int (Wnt)/-catenin signaling pathway played a role in the PPI-induced growth inhibition in MM cells. The canonical Wnt signaling pathway is activated in MM cells through constitutively active -catenin, a messenger molecule relevant to growth, survival, and migration of MM cells. Western blotting was used to measure the protein levels of -catenin, and PPI treatment led to downregulating the expression of -catenin protein and was followed by inhibition of -catenin nuclear localization. As a result, -catenin downstream targets, such as cyclin D1 and survivin, were downregulated. To the best of our knowledge, this is the first report identifying anti-proliferative potency of PPI against myeloma cells. PPI blocks -catenin nuclear translocation and decreasing expression of the downstream targets of -catenin. Our results suggest that PPI is a novel inhibitor of -catenin activity with potential anti-myeloma efficacy.

Deguelin, a Natural Rotenoid, Inhibits Mouse Myeloma Cell Growth in Vitro Via Induction of Apoptosis.

Deguelin Induces Apoptosis in Colorectal Cancer Cells by Activating the P38 MAPK Pathway.

Deguelin Exerts Anticancer Activity of Human Gastric Cancer MGC-803 and MKN-45 Cells in Vitro

Deguelin Inhibits Proliferation and Migration of Human Pancreatic Cancer Cells in Vitro Targeting Hedgehog Pathway.

Antitumor Effects of Deguelin on H460 Human Lung Cancer Cells in Vitro and in Vivo: Roles of Apoptotic Cell Death and H460 Tumor Xenografts Model.

Deguelin Inhibits the Migration and Invasion of U-2 OS Human Osteosarcoma Cells via the Inhibition of Matrix Metalloproteinase-2/-9 in Vitro

Deguelin Attenuates Non-Small-Cell Lung Cancer Cell Metastasis by Upregulating PTEN/KLF4/EMT Signaling Pathway.

Deguelin Impairs Cell Adhesion, Migration And Invasion Of Human Lung Cancer Cells Through The Nf-Kappa B Signaling Pathways

Studies on the Mechanism of Deguelin-induced Apoptosis of Human Prostate Cancer Cell Lines

Quercetin induces cell apoptosis of myeloma and displays a synergistic effect with dexamethasone in vitro and in vivo xenograft models.

Deguelin Induces The Apoptosis Of Lung Squamous Cell Carcinoma Cells Through Regulating The Expression Of Galectin-1

Biopharmacological Considerations for Accelerating Drug Development of Deguelin, a Rotenoid with Potent Chemotherapeutic and Chemopreventive Potential

Deguelin Impairs Cell Adhesion, Migration and Invasion of Human Lung Cancer Cells through the NF-[Formula: see text]B Signaling Pathways.

Polyphyllin I Induces Cell Cycle Arrest and Apoptosis in Human Myeloma Cells Via Modulating Β‐catenin Signaling Pathway

Deguelin inhibits the glioblastoma progression through suppressing CCL2/NFκB signaling pathway

Enhancement Radiosensitization Of Breast Cancer Cells By Deguelin

Effects of deguelin on proliferation and apoptosis of gastric cancer cells MKN-45

Recent Advances in Chemotherapeutic Implications of Deguelin: A Plant-Derived Retinoid

Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin

Deguelin Attenuates Allergic Airway Inflammation Via Inhibition Of Nf-Kappa B Pathway In Mice

Berbamine, a Novel Nuclear Factor Κb Inhibitor, Inhibits Growth and Induces Apoptosis in Human Myeloma Cells